文献速递肥胖与代谢综合征糖尿病

HAND2:受糖皮质激素信号调控的新型肥胖相关脂肪生成转录因子

HAND2 is a novel obesity-linked adipogenic transcription factor regulated by glucocorticoid signalling.
PubMed 文献 · Diabetologia · 2021-05-20

该研究探讨HAND2在脂肪生成中的作用。人白色脂肪组织(WAT)来自两项横断面研究(318人和96人),体外使用人原代脂肪细胞、小鼠原代脂肪细胞及人多能脂肪来源干细胞(hMADS),并通过条件性脂肪细胞Hand2敲除小鼠进行体内代谢测试。结果显示HAND2是肥胖相关的白色脂肪细胞转录因子,受糖皮质激素通过GR调控,在体外为脂肪细胞分化所必需但非充分,且其作用阶段早于Adipoq表达。

要点

  • HAND2是肥胖相关的白色脂肪细胞转录因子,受糖皮质激素-GR通路调控。
  • 体外沉默HAND2损害脂肪细胞分化,但体内Adipoq-Cre条件敲除未重现该表型。
  • HAND2在分化早期诱导,其作用阶段早于Adipoq表达。

核心结论

  • HAND2是新型肥胖相关脂肪细胞转录因子,揭示GR依赖的脂肪生成新机制。

研究设计与样本

  • 人WAT来自两项横断面研究(318人和96人);体外用人及小鼠原代脂肪细胞和hMADS细胞;体内用Adipoq-Cre条件性脂肪细胞Hand2敲除小鼠。

主要发现

  • 人WAT中HAND2表达与BMI相关。
  • HAND2在白色脂肪细胞中富集(相较于棕色),分化早期诱导,并响应地塞米松(DEX)。
  • 沉默NR3C1或条件性敲除GR导致HAND2表达下降,确立GR调控HAND2。
  • 沉默HAND2损害hMADS和小鼠原代脂肪细胞分化。
  • Adipoq-Cre条件性脂肪细胞Hand2敲除小鼠未重现脂肪组织分化受损,提示HAND2作用于Adipoq表达之前阶段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Adipocytes are critical cornerstones of energy metabolism. While obesity-induced adipocyte dysfunction is associated with insulin resistance and systemic metabolic disturbances, adipogenesis, the formation of new adipocytes and healthy adipose tissue expansion are associated with metabolic benefits. Understanding the molecular mechanisms governing adipogenesis is of great clinical potential to efficiently restore metabolic health in obesity. Here we investigate the role of heart and neural crest derivatives-expressed 2 (HAND2) in adipogenesis. METHODS: Human white adipose tissue (WAT) was collected from two cross-sectional studies of 318 and 96 individuals. In vitro, for mechanistic experiments we used primary adipocytes from humans and mice as well as human multipotent adipose-derived stem (hMADS) cells. Gene silencing was performed using siRNA or genetic inactivation in primary adipocytes from loxP and or tamoxifen-inducible Cre-ERT2 mouse models with Cre-encoding mRNA or tamoxifen, respectively. Adipogenesis and adipocyte metabolism were measured by Oil Red O staining, quantitative PCR (qPCR), microarray, glucose uptake assay, western blot and lipolysis assay. A combinatorial RNA sequencing (RNAseq) and ChIP qPCR approach was used to identify target genes regulated by HAND2. In vivo, we created a conditional adipocyte Hand2 deletion mouse model using Cre under control of the Adipoq promoter (Hand2AdipoqCre) and performed a large panel of metabolic tests. RESULTS: We found that HAND2 is an obesity-linked white adipocyte transcription factor regulated by glucocorticoids that was necessary but insufficient for adipocyte differentiation in vitro. In a large cohort of humans, WAT HAND2 expression was correlated to BMI. The HAND2 gene was enriched in white adipocytes compared with brown, induced early in differentiation and responded to dexamethasone (DEX), a typical glucocorticoid receptor (GR, encoded by NR3C1) agonist. Silencing of NR3C1 in hMADS cells or deletion of GR in a transgenic conditional mouse model results in diminished HAND2 expression, establishing that adipocyte HAND2 is regulated by glucocorticoids via GR in vitro and in vivo. Furthermore, we identified gene clusters indirectly regulated by the GR-HAND2 pathway. Interestingly, silencing of HAND2 impaired adipocyte differentiation in hMADS and primary mouse adipocytes. However, a conditional adipocyte Hand2 deletion mouse model using Cre under control of the Adipoq promoter did not mirror these effects on adipose tissue differentiation, indicating that HAND2 was required at stages prior to Adipoq expression. CONCLUSIONS/INTERPRETATION: In summary, our study identifies HAND2 as a novel obesity-linked adipocyte transcription factor, highlighting new mechanisms of GR-dependent adipogenesis in humans and mice. DATA AVAILABILITY: Array data have been submitted to the GEO database at NCBI (GSE148699).

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Giroud M, Tsokanos FF, Caratti G, et al. HAND2 is a novel obesity-linked adipogenic transcription factor regulated by glucocorticoid signalling. Diabetologia. 2021. PMID: 34014371. doi:10.1007/s00125-021-05470-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。